Počet záznamů: 1
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
- 1.
SYSNO 0510823 Název Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells Tvůrce(i) Knox, T. (US)
Sahakian, E. (US)
Banik, D. (US)
Hadley, M. (US)
Palmer, E. (US)
Noonepalle, S. (US)
Kim, J. (US)
Powers, J. (US)
Gracia-Hernandez, M. (US)
Oliveira, V. (US)
Cheng, F. (US)
Chen, J. (US)
Bařinka, Cyril (BTO-N) RID, ORCID
Pinilla-Ibarz, J. (US)
Lee, N. H. (US)
Kozikowski, A. (US)
Villagra, A. (US)Zdroj.dok. Scientific Reports. Roč. 9, APR 16 2019 (2019). - : Nature Publishing Group Číslo článku 6136 Druh dok. Článek v odborném periodiku Institucionální podpora BTO-N - RVO:86652036 Jazyk dok. eng Země vyd. GB Klíč.slova HISTONE DEACETYLASE 6 * LIGAND 1 EXPRESSION * INFILTRATING LYMPHOCYTES URL https://www.nature.com/articles/s41598-019-42237-3 Trvalý link http://hdl.handle.net/11104/0301209
Počet záznamů: 1